French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV
NCT ID: NCT05953558
Last Updated: 2023-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2023-05-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
NCT04463641
Danish Randomized Trial on Leadless vs Transvenous Pacing
NCT05856799
LEft Atrial Pacing in Diastolic Heart Failure
NCT01618981
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm
NCT06835491
Effect of Leadless Pacing on Heart Function
NCT06100757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients implanted with Micra AV
The first 1000 patients implanted by the device in France
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHU de Tours
UNKNOWN
European Georges Pompidou Hospital
OTHER
Hôpital privé Clairval - Marseille
UNKNOWN
Clinique Pasteur Toulouse
OTHER
University Hospital, Bordeaux
OTHER
Infirmerie Protestante Lyon
AMBIG
Institut Jacques Cartier - Massy
UNKNOWN
University Hospital, Grenoble
OTHER
Hôpital de la Timone
OTHER
University Hospital, Toulouse
OTHER
Hopital Prive Saint Martin - Bordeaux
UNKNOWN
Hospices Civils de Lyon
OTHER
CHU de Rouen - Accueil
OTHER
University Hospital, Caen
OTHER
Médipôle Lyon-Villeurbanne
OTHER
Hospital Ambroise Paré Paris
OTHER
Clinique Saint Augustin - Bordeaux
UNKNOWN
Rennes University Hospital
OTHER
Clinique de la Sauvegarde - Lyon
UNKNOWN
University Hospital of Saint-Etienne
OTHER
Hôpital Privé de Parly II - Le Chesnay
OTHER
Institut Mutualiste Montsouris
OTHER
Centre Hospitalier Universitaire, Amiens
OTHER
University Hospital, Clermont-Ferrand
OTHER
Centre Hospitalier Régional et Universitaire de Brest
OTHER
Poitiers University Hospital
OTHER
Clinique Saint-Gatien - Tours
UNKNOWN
CHU de Reims
OTHER
Centre Hospitalier Universitaire de Besancon
OTHER
Centre Hospitalier Universitaire Dijon
OTHER
Hôpital Privé de Lille Métropole
UNKNOWN
University Hospital, Montpellier
OTHER
University Hospital, Strasbourg, France
OTHER
Nantes University Hospital
OTHER
Centre Cardio-Thoracique de Monaco
UNKNOWN
Hospital St. Joseph, Marseille, France
OTHER
Centre Hospitalier Régional Metz-Thionville
OTHER
Centre Hospitalier Annecy Genevois
OTHER
Clinique du Millenaire
OTHER
University Hospital, Limoges
OTHER
Clinique Saint Pierre - Perpignan
UNKNOWN
Bichat Hospital
OTHER
Universite de La Reunion
OTHER
CHU de Lille
UNKNOWN
Institute Arnault Tzanck, France
OTHER
Hôpital Privé Les Franciscaines
OTHER
CHU de Fort de France - Martinique
UNKNOWN
Henri Mondor University Hospital
OTHER
University Hospital, Angers
OTHER_GOV
Centre Hospitalier de Lens
OTHER
Central Hospital, Nancy, France
OTHER
Paris Sudden Death Expertise Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eloi Marijon, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Paris Sudden Death Expertise Center
Fawzi Kerkouri, MD
Role: PRINCIPAL_INVESTIGATOR
University hospital of Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Paris Cardiovascular Research Centre (AV-CESAR Investigators)
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A00023-42 Protocole
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.